Resultaten

…et al. Isatuximab Plus Carfilzomib and Dexamethasone Vs Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma (IKEMA): Interim Analysis of a Phase 3, Randomized, Open-Label Study. ASH 2020. Abstract 2316. Seigel…

…survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. Br J Haematol 2015;170(4):504-14. Dunleavy K, Fanale MA, Abramson JS, et al. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide,…

…stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica 2012;97:1142-1148. Bacigalupo A et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin…

…2017 Nov;4(11):e510-e523 Bromberg et al. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG…

…al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006;108:419. Fenaux, P., et al. Efficacy of azacitidine compared with that of…

…met behulp van de REMA-score (3). Variabel Score Geslacht Man +1 Vrouw -1 Klinische symptomen bij anafylaxie Afwezigheid van urticaria en angio-oedeem +1 Urticaria en/of angio-oedeem -2 (Pre-) syncope +3…

…newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis. Haematologica 2018;103(1):163-171. Mithoowani S, Gregory-Miller K, Goy J, et al. High-dose dexamethasone compared with prednisone for previously untreated primary…

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 27-9-2024, 0:49